Literature DB >> 6095806

Identification of the angiotensin II receptor in rat mesenteric artery.

J McQueen, G D Murray, P F Semple.   

Abstract

Specific binding sites of high affinity and low capacity for 125I-angiotensin II have been identified in a membrane fraction derived from arterial arcades of the rat mesentery. Heterogeneity of binding sites and extensive tracer degradation necessitated the use of nonlinear regression methods for the analysis of radioligand binding data. Forward and reverse rate constants for the high affinity sites obtained by three experimental approaches were in good agreement and gave a dissociation equilibrium constant (Kd) of 19-74 pM (95% confidence interval). Affinities for a number of angiotensin-related peptides calculated from competitive binding curves were in the order 125I-angiotensin II = angiotensin II greater than angiotensin III greater than [Sar1,Ile8]angiotensin II greater than [Sar1,Gly8]angiotensin II. Angiotensin I and biochemically unrelated peptides had virtually no effect on binding of tracer angiotensin II. The divalent cations Mn2+, Mg2+ and Ca2+ stimulated 125I-angiotensin II binding at concentrations of 2-10 mM, as did Na+ at 50-100 mM. In the presence of Na+ or Li+, K+ had a biphasic effect. The chelating agents EDTA and EGTA were inhibitory, as were the thiol reagents dithiothreitol and cysteine. This study defined angiotensin II binding sites in a vascular target tissue of sufficiently high affinity to interact rapidly with plasma angiotensin II at physiological concentrations.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6095806      PMCID: PMC1144349          DOI: 10.1042/bj2230659

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  33 in total

1.  Angiotensin receptors in rat uterine membranes.

Authors:  B Rouzaire-Dubois; M A Devynck; E Chevillotte; P Meyer
Journal:  FEBS Lett       Date:  1975-07-15       Impact factor: 4.124

2.  Radioimmunoassay and pharmacokinetics of saralasin in the rat and hypertensive patients.

Authors:  W A Pettinger; K Keeton; K Tanaka
Journal:  Clin Pharmacol Ther       Date:  1975-02       Impact factor: 6.875

3.  THE EFFECT OF ANGIOTENSIN II ON THE BLOOD PRESSURE IN HUMANS WITH HYPERTENSIVE DISEASE.

Authors:  N M KAPLAN; J G SILAH
Journal:  J Clin Invest       Date:  1964-04       Impact factor: 14.808

4.  Kinetics of gonadotropin binding by receptors of the rat testis. Analysis by a nonlinear curve-fitting method.

Authors:  J M Ketelslegers; G D Knott; K J Catt
Journal:  Biochemistry       Date:  1975-07-15       Impact factor: 3.162

Review 5.  Agents which block the action of the renin-angiotensin system.

Authors:  J O Davis; R H Freeman; J A Johnson; W S Spielman
Journal:  Circ Res       Date:  1974-03       Impact factor: 17.367

6.  Properties of angiotensin II receptors in the bovine and rat adrenal cortex.

Authors:  H Glossmann; A J Baukal; K J Catt
Journal:  J Biol Chem       Date:  1974-02-10       Impact factor: 5.157

7.  Pharmacologic receptor activity of rabbit aorta. Effect of dithiothreitol and N-ethylmaleimide.

Authors:  J H Fleisch; M C Krzan; E Titus
Journal:  Circ Res       Date:  1973-09       Impact factor: 17.367

8.  Dose-response curves for angiotensin II and synthetic analogues in three types of smooth muscle: existence of different forms of receptor sites for angiotensin II.

Authors:  A Papadimitriou; M Worcel
Journal:  Br J Pharmacol       Date:  1974-02       Impact factor: 8.739

9.  Sodium and potassium intake, blood pressure, and pressor response to angiotensin.

Authors:  W D Reid; J H Laragh
Journal:  Proc Soc Exp Biol Med       Date:  1965-10

10.  Prior receptor occupancy as a determinant of the pressor activity of infused angiotensin II in the rat.

Authors:  H Thurston; J H Laragh
Journal:  Circ Res       Date:  1975-01       Impact factor: 17.367

View more
  1 in total

1.  Angiotensin II-elicited signal transduction via AT1 receptors in endothelial cells.

Authors:  M E Pueyo; N N'Diaye; J B Michel
Journal:  Br J Pharmacol       Date:  1996-05       Impact factor: 8.739

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.